TMT101 Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TMT101 Injection, covering 2025-08-11 to 2025-08-11. Get the full timeline:
Most recent: Clinical Trial Update: The Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patients With Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC) [Phase 1]